• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MyMS:芬兰多发性硬化症患者自我报告结果的界面

MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis.

作者信息

Hämäläinen Päivi, Viitala Matias, Kuusisto Hanna, Ruutiainen Juhani, Soilu-Hänninen Merja

机构信息

From the Department of Psychology and Speech-Language Pathology, University of Turku, Turku, Finland.

The Finnish Neuro Society, Masku, Finland.

出版信息

Int J MS Care. 2024 Oct 7;26(Q4):273-280. doi: 10.7224/1537-2073.2023-082. eCollection 2024 Oct.

DOI:10.7224/1537-2073.2023-082
PMID:39386272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459352/
Abstract

BACKGROUND

Patient-generated data are a cornerstone of individualized multiple sclerosis (MS) treatment. MyMS, an interface for patient-reported outcomes (PROs) was developed by the Finnish MS Register to enable systematic collection of PROs.

METHODS

MyMS collects data on demographics, lifestyle factors, disease-related factors, and validated questionnaires, including the Quality of Life Questionnaire (15D), the Multiple Sclerosis Impact Scale (MSIS-29), and the Fatigue Severity Scale (FSS). At the end of 2020, the patient-reported Expanded Disability Status Scale (PREDSS), the EuroQOL-5 Dimension (EQ-5D), the Fatigue Scale for Motor and Cognitive Functions (FSMC), and the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) were added.

RESULTS

As of January 1, 2023, 1201 individuals with MS (79% female) have added data to MyMS. Of the validated PRO measures (PROMs), the 15D, MSIS-29, and FSS are the most used. The mean PREDSS score is 3.0 and median disease duration is 6.4 years. According to the existing PROMs, patients report mildly compromised quality of life and problems with fatigue and cognition.

CONCLUSIONS

The patient interface of the Finnish MS Register consists of data from 17 of 21 counties with well-being services. The interface is used by 10% of Finnish individuals with MS. The addition of the PREDSS, EQ-5D, FSMC, and MSNQ to the interface has increased health care professional and patient interest in the use of PROMs. We suggest that PROs should be integrated into electronic health records to improve shared decision-making and diminish documentation burden.

摘要

背景

患者生成的数据是个体化多发性硬化症(MS)治疗的基石。芬兰MS登记处开发了MyMS这一患者报告结局(PRO)界面,以实现PRO的系统收集。

方法

MyMS收集人口统计学、生活方式因素、疾病相关因素以及经过验证的问卷数据,包括生活质量问卷(15D)、多发性硬化症影响量表(MSIS - 29)和疲劳严重程度量表(FSS)。在2020年底,增加了患者报告的扩展残疾状态量表(PREDSS)、欧洲五维健康量表(EQ - 5D)、运动和认知功能疲劳量表(FSMC)以及多发性硬化症神经心理学问卷(MSNQ)。

结果

截至2023年1月1日,1201名MS患者(79%为女性)已向MyMS添加数据。在经过验证的PRO测量指标(PROMs)中,15D、MSIS - 29和FSS是使用最多的。PREDSS平均得分为3.0,疾病中位持续时间为6.4年。根据现有的PROMs,患者报告生活质量轻度受损,存在疲劳和认知问题。

结论

芬兰MS登记处的患者界面包含来自21个设有福利服务的县中的17个县的数据。该界面被10%的芬兰MS患者使用。在界面中添加PREDSS、EQ - 5D、FSMC和MSNQ增加了医疗保健专业人员和患者对使用PROMs的兴趣。我们建议应将PRO整合到电子健康记录中,以改善共同决策并减轻记录负担。

相似文献

1
MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis.MyMS:芬兰多发性硬化症患者自我报告结果的界面
Int J MS Care. 2024 Oct 7;26(Q4):273-280. doi: 10.7224/1537-2073.2023-082. eCollection 2024 Oct.
2
Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC).芬兰版多发性硬化症简易国际认知评估量表(BICAMS)的验证以及多发性硬化症神经心理问卷(MSNQ)和运动与认知功能疲劳量表(FSMC)的适用性评估。
Brain Behav. 2021 Jun;11(6):e02087. doi: 10.1002/brb3.2087. Epub 2021 May 7.
3
Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.在一个与认知、磁共振成像(MRI)及身体状况相关的继发进展型多发性硬化症队列中患者报告的结果。
Mult Scler Relat Disord. 2023 Mar;71:104550. doi: 10.1016/j.msard.2023.104550. Epub 2023 Feb 5.
4
Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.多发性硬化症影响量表-29 芬兰语版的有效性和可靠性。
Brain Behav. 2017 May 17;7(7):e00725. doi: 10.1002/brb3.725. eCollection 2017 Jul.
5
Impact of multiple sclerosis phenotypes on burden of disease in Finland.多发性硬化症表型对芬兰疾病负担的影响。
J Med Econ. 2020 Feb;23(2):156-165. doi: 10.1080/13696998.2019.1682004. Epub 2019 Nov 7.
6
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.全国多发性硬化症队列中患者报告的疲劳症状严重程度的预测因素
Mult Scler Relat Disord. 2023 Feb;70:104481. doi: 10.1016/j.msard.2022.104481. Epub 2022 Dec 23.
7
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.NOVA 研究的探索性临床疗效和患者报告结局:静脉注射那他珠单抗 6 周给药与持续 4 周给药治疗复发缓解型多发性硬化症的随机对照研究。
Mult Scler Relat Disord. 2023 Apr;72:104561. doi: 10.1016/j.msard.2023.104561. Epub 2023 Feb 11.
8
Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients.芬兰多发性硬化症患者疲劳严重程度量表的有效性和可靠性。
Brain Behav. 2017 Jun 9;7(7):e00743. doi: 10.1002/brb3.743. eCollection 2017 Jul.
9
The reliability and validity of the Turkish version of the multiple sclerosis impact scale-29.多发性硬化症影响量表-29 土耳其语版的信度和效度。
Turk J Med Sci. 2022 Aug;52(4):1216-1222. doi: 10.55730/1300-0144.5426. Epub 2022 Aug 10.
10
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.

引用本文的文献

1
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study.基于芬兰登记处的多发性硬化症疲劳和认知问题筛查与管理方案:观察性研究
JMIR Hum Factors. 2025 Aug 22;12:e67990. doi: 10.2196/67990.
2
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registry.利用芬兰多发性硬化症登记处评估患者感知的疲劳情况。
Mult Scler J Exp Transl Clin. 2025 Mar 18;11(1):20552173251325098. doi: 10.1177/20552173251325098. eCollection 2025 Jan-Mar.

本文引用的文献

1
Information Provision and Quality. A Pilot Study on Shared Decision-Making in Multiple Sclerosis.信息提供与质量。多发性硬化症中共享决策的试点研究。
Stud Health Technol Inform. 2022 Jun 29;295:179-182. doi: 10.3233/SHTI220691.
2
NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.多发性硬化症中的NARCOMS及其他登记系统:问题与见解
Int J MS Care. 2021 Nov-Dec;23(6):276-284. doi: 10.7224/1537-2073.2020-133. Epub 2021 Dec 29.
3
Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC).芬兰版多发性硬化症简易国际认知评估量表(BICAMS)的验证以及多发性硬化症神经心理问卷(MSNQ)和运动与认知功能疲劳量表(FSMC)的适用性评估。
Brain Behav. 2021 Jun;11(6):e02087. doi: 10.1002/brb3.2087. Epub 2021 May 7.
4
"I Will Respect the Autonomy of My Patient": A Scoping Review of Shared Decision Making in Multiple Sclerosis.“我将尊重患者的自主权”:多发性硬化症共同决策的范围综述
Int J MS Care. 2020 Nov-Dec;22(6):285-293. doi: 10.7224/1537-2073.2020-027. Epub 2020 Dec 28.
5
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.一种电子、无需监督的多发性硬化症扩展残疾状况量表患者报告版本。
Mult Scler. 2021 Aug;27(9):1432-1441. doi: 10.1177/1352458520968814. Epub 2020 Nov 25.
6
Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes.衡量多发性硬化症患者最重要的结果:患者报告结局的作用。
Curr Opin Neurol. 2020 Jun;33(3):295-299. doi: 10.1097/WCO.0000000000000821.
7
Multiple sclerosis in Finland 2018-Data from the national register.2018 年芬兰多发性硬化症报告——国家注册中心数据
Acta Neurol Scand. 2019 Nov;140(5):303-311. doi: 10.1111/ane.13145. Epub 2019 Jul 29.
8
Multiple sclerosis registries in Europe - An updated mapping survey.欧洲的多发性硬化症登记处——一项最新的图谱调查。
Mult Scler Relat Disord. 2019 Jan;27:171-178. doi: 10.1016/j.msard.2018.09.032. Epub 2018 Oct 4.
9
Predicting risk of secondary progression in multiple sclerosis: A nomogram.预测多发性硬化症的继发进展风险:列线图。
Mult Scler. 2019 Jul;25(8):1102-1112. doi: 10.1177/1352458518783667. Epub 2018 Jun 18.
10
The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis.自评疲劳和主观认知障碍对工作能力的影响:以多发性硬化症为例。
Mult Scler. 2019 Apr;25(5):740-749. doi: 10.1177/1352458518769837. Epub 2018 Apr 17.